Pharmacovigilancein Post Stroke Patient’s: A Cross Section Prospective Analysis

Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2017, Vol 3, Issue 3

Abstract

Abstract: Drug related adverse effects may be minor or major. Pharmacists have an ethical obligation to notify the appropriate bodies whenever adverse effects where suspected. Stroke affect one’s physical and communication abilities, as well as causing emotional changes and difference in behaviour. The study underlines the importance of monitoring stoke survivors emotional and behaviour alternation. The objective is to determine the drug utilization review in post stroke patients and to assess the adverse reactions in stroke management. Cross-sectional prospective study was performed for six-month and the patients diagnosed as stroke and wished to participate were identified. All the subjects were evaluated for adverse drug reactions through telephonic or face to face interview. Out of 52 patients 71.15% were males and 28.84% females. The mean age of the patients was 63.21 (±10.19) years and 61% patients had Blood Pressure, followed by 55% Dyslipidymia, 42% Diabetes Mellitus. A total of 38 incidences of ADRs were observed during the study period for 15 patients. The highest reported ADR was GI bleeding (17.3%) followed by GI Distress and Constipation. Causality of ADRs found to have probable 74%, possible 23.6% and definite 2.6% and no doubtful categories. The study results cleared that majority of the stroke patients have adequately severe neurological impairment and need assistance to carryout activities of daily living. Majority of the patients seems to have mistaken the symptoms of ADR to be due to the disease being treated and old age. Drug utilisation studies should be carried out in large number of population and at different locations which helps to reduce the drug related problems and improve the rational use of drugs by the patients. Keywords: Post Stoke, ADR, DUE, Quality of life

Authors and Affiliations

Kiron SS, Sheeba Damodar, Susmitha G, Saritha M

Keywords

Related Articles

CymbopogoncitratusStapf(DC) extracts alleviate gasoline vapour-induced metabolic disorders and cardiovascular disease risk in rats

Abstract: Alternative therapies for the alleviation of chemical/xenobiotic-induced metabolic aberrations and risk factors for cardiovascular disease have been inadequately explored, despite their rich cardiovascula...

The Impact of Occupational Stress on Nurses Caring Behavior and Their Health Related Quality of Life

Abstract:Stress has been seen as a routine and accepted part of the health care worker’s role there is a wonderful research on stress in nurses worldwide. The interaction among stress and caring behaviors remains quite n...

Determination of Blood Levels of Lead in Pregnant Women in Nnewi, Anambra State, South Eastern Nigeria

Lead is a well known environmental and reproductive toxicant. This study was designed to evaluate the blood lead levels in pregnant women in Nnewi, Anambra State, South Eastern Nigeria. A total of 100 apparently healthy...

Tai Chi as a Physiotherapeutic Approach against Osteoarthritis and Oxidative Stress

Abstract:Osteoarthritis (OA) is the most prevalent degenerative joint disease and the most important reason of the physical disability in the elderly population. Along with the fact that OA pathogenesis is not fully know...

The Efficacy of Intermittent Pneumatic Compression Device as an Alternative Measure to Pharmacological Prophylaxis for Venous Thromboembolism in Postoperative and Post-Trauma Patients: An Integrative Review

Abstract: Thromboprophylaxis methods mainly include pharmacological and mechanical options, such as intermittent pneumatic compression devices (IPCDs). In a specific population (post-operative and post-traumatic patients...

Download PDF file
  • EP ID EP390373
  • DOI -
  • Views 192
  • Downloads 0

How To Cite

Kiron SS, Sheeba Damodar, Susmitha G, Saritha M (2017). Pharmacovigilancein Post Stroke Patient’s: A Cross Section Prospective Analysis. Saudi Journal of Medical and Pharmaceutical Sciences, 3(3), 235-238. https://europub.co.uk/articles/-A-390373